Implementation of the ESPEN guideline on clinical nutrition in the intensive care unit (ICU): It is time to move forward!: A position paper from the 'nutrition in the ICU' ESPEN special interest group
- PMID: 37739675
- DOI: 10.1016/j.clnesp.2023.06.033
Implementation of the ESPEN guideline on clinical nutrition in the intensive care unit (ICU): It is time to move forward!: A position paper from the 'nutrition in the ICU' ESPEN special interest group
Abstract
Nutritional assessment and provision of nutritional therapy are a core part of intensive care unit (ICU) patient treatment. The ESPEN guideline on clinical nutrition in the ICU was published in 2019. However, uncertainty and difficulties remain regarding its full implementation in daily practice. This position paper is intended to help ICU healthcare professionals facilitate the implementation of ESPEN nutrition guidelines to ensure the best care for their patients. We have aimed to emphasize the guideline recommendations that need to be implemented in the ICU, are advised, or are optional, and to give practical directives to improve the guideline recommendations in daily practice. These statements were written by the members of the ICU nutrition ESPEN special interest group (SIG), based on a survey aimed at identifying current practices relating to key issues in ICU nutrition. The ultimate goal is to improve the ICU patients quality of care.
Keywords: Body composition; Critical illness; Enteral nutrition; Indirect calorimetry; Malnutrition; Supplemental parenteral nutrition.
Copyright © 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest Ronan Thibault received consulting and conference fees: Aguettant, Baxter, BBraun, Boehringer Ingelheim, Fresenius-Kabi, Nestlé Health Science, Nutricia, Roche, Servier; conference fees: Astra-Zeneca, Homeperf, Lactalis, Le Cancer; research support: Takeda-Shire, Valorex. Danielle E. Bear has received consulting fees from Avanos and Cardinal Health and speaker fees from Cardinal Health and Baxter. Juan Carlos Montejo Gonzalez has received speaker fees from Abbott, Baxter, Fresenius Kabi, and Vegenat. Michael Hiesmayr has received board membership and consulting fees from Fresenius-Kabi, and speaker fees from Baxter and Fresenius Kabi. Mehmet Uyar has received speaker fees from Abbott, Baxter, Fresenius, Nestlé. Elisabeth de Waele has received research grants from Baxter and Danone, and speaker fees from ART Medical, Baxter, and Danone. Steffen Weber-Carstens has received consulting fees from Dräger. Pierre Singer received consulting and conference fees: Baxter, Fresenius Kabi, Cosmed, conference fees: Nestle, Nutricia, consulting fees: ART medical, and grants from Fresenius Kabi, ART medical, and B Braun. Arabella Fischer and Péter Tamási declare no conflict of interest.
MeSH terms
LinkOut - more resources
Full Text Sources